News

PharmiWeb1d
Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...
PharmiWeb1d
Action Behavior Centers Hosts Community Impact Event with Special Olympics During ABCaba Clinical Conference
AUSTIN, TX / ACCESS Newswire / June 20, 2025 / Action Behavior Centers, a leading provider of compassionate applied behavior analysis (ABA) therapy for children with autism, hosted its inaugural ...
PharmiWeb1d
DeepEcho Reaches New Milestone With FDA 510(k) Clearance for AI-Powered Prenatal Imaging
NEW YORK, NY AND RABAT, MOROCCO / ACCESS Newswire / June 20, 2025 / DeepEcho, an AI first healthtech company revolutionizing maternal and fetal health, has received clearance from the U.S. Food and ...
PharmiWeb1d
Dr. John Peloza to Join Keynote Panel at Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC Conference
CHICAGO, IL / ACCESS Newswire / June 20, 2025 / Dr. John Peloza, internationally recognized spine surgeon and innovator in spinal motion preservation, will join the keynote panel "Cervical ...
PharmiWeb1d
KLAS Research, St. Luke's Health System, and Ambience Healthcare Unveil Groundbreaking Impact Study on Ambient AI
Independent report confirms Ambience Healthcare's AI platform reduces clinician burnout, enhances patient care, and strengthens financial and compliance outcomes SAN FRANCISCO, CA / ACCESS Newswire / ...
PharmiWeb1d
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on ...
PharmiWeb1d
The Dawn of New Beginnings: Navigating the Assisted Reproductive Technology Market
In a world increasingly shaped by scientific advancement and evolving societal norms, the realm of human reproduction has ...
PharmiWeb1d
DARZALEX® (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple myeloma
If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...
PharmiWeb1d
IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous ...
Pending the European Commission final decision, regimen offers a new standard of care for eligible MCL patients[1],[2] Positive opinion reinforces Phase 3 TRIANGLE study results by the European MCL ...
PharmiWeb1d
IKS Health Earns Top Ranking in Black Book's 2025 Survey for AI-Driven Claims Integrity and Denial Management Services
Exhibiting Next Week at HFMA Annual Conference in Denver DENVER, COLORADO / ACCESS Newswire / June 20, 2025 / IKS Health has been named the top-rated provider of outsourced Revenue Cycle Management ...
PharmiWeb1d
Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumorsNew candidate APVO455 targets Nectin-4+ cancers, joins ...
PharmiWeb1d
Magnetic Resonance Imaging (MRI) Market to Reach USD 9.76 Bn by 2035, Growing at 4.2% CAGR Globally
The global MRI market will rise from USD 6.47 billion in 2025 to USD 9.76 billion by 2035, growing at a CAGR of 4.2%. By product type, closed MRI systems will dominate with a 68.5% share in 2025, ...